This article refers to 'Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry' by G. von Olshausen et al., published in this issue on pages 1636-1646.Atrial fibrillation (AF) and heart failure (HF) are two common cardiac diseases, affecting 1-2% of the population with a prevalence that rises steeply with age. 1 They are conditioned and promoted by common risk factors and frequently coexist with complex dynamic interactions 1 (Figure 1). Although left ventricular ejection fraction (LVEF) shows substantial limitations in terms of imprecision, intra-, and inter-observer variability, 2 the classification of patients with HF is currently based on three different categories according to LVEF, i.e. patients with preserved (HFpEF, LVEF ≥50%), mildly reduced (HFmrEF, LVEF 41-49%), and reduced ejection fraction (HFrEF, LVEF ≤40%). 3 HFpEF is estimated to account for approximately half of HF cases, even if its epidemiological profile is of complex assessment in consideration of the lack of standardized criteria for its diagnosis in the past and substantial heterogeneity in clinical presentation, underlying aetiology, precipitating factors, and associated comorbidities. 4 The haemodynamic consequences of AF are related to loss of atrial contribution to cardiac output, to increase in heart rate with shortening in the duration of diastole, and to irregularity in diastolic intervals. Loss of atrial transport is particularly significant if there is impairment in left ventricular (LV) filling, due to reduced diastolic compliance, as in many cases of HFpEF. In this patient subset, a high heart rate or an irregular heart rate with frequent short diastolic intervals may be poorly tolerated as well, resulting in increased capillary wedge pressure. 5 Apart from these considerations, it is well acknowledged that a sustained uncontrolled tachycardia with heart rate >120 bpm may be associated at long term with an impairment of LV function, which may result in important worsening of the clinical conditions, unless heart rate can be controlled or sinusThe opinions expressed in this article are not necessarily those of the Editors of the European Journal of Heart Failure or of the European Society of Cardiology.